Gene · 3817
Papers1,753
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,753
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bifunctional covalent organic framework for rapid isolation of extracellular vesicles and proteomics-based biomarker discovery. | Talanta | 2027 | 42391702 | PubTator, text mining | PubMed |
| Fe3O4-Au cluster-satellite particles as direct colorimetric reporters in a smartphone-quantified lateral flow immunoassay for prostate-specific antigen. | Mikrochim Acta | 2026 | 42789117 | PubTator, text mining | PubMed |
| Artificial neural network engineering of high carrier mobility single-layer graphene interfaces for ultrasensitive FET-aptasensors in clinical PSA detection. | Biosens Bioelectron | 2026 | 42659930 | PubTator, text mining | PubMed |
| Expression patterns of potential targets for antibody-directed therapy in metastatic castration-resistant prostate cancer patients. | Eur J Cancer | 2026 | 42623835 | PubTator, text mining | PubMed |
| Targeting human kallikrein 2 in prostate cancer. | Clin Adv Hematol Oncol | 2026 | 42283714 | PubTator, text mining | PubMed |
| Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer. | Mol Cancer Res | 2026 | 42189191 | PubTator, text mining | PubMed |
| Evaluation of Tissue from Patients with Prostate Cancer Identifies B7-H3 as an Androgen-Regulated, Broadly Expressed, Combinatorial Therapeutic Target. | Clin Cancer Res | 2026 | 42053993 | PubTator, text mining | PubMed |
| Spatial Robustness of Prostate Cancer Biomarkers Evaluated by Spatial Transcriptomics. | Prostate | 2026 | 41911496 | PubTator, text mining | PubMed |
| Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model. | Eur Urol Focus | 2026 | 41864782 | PubTator, text mining | PubMed |
| Editorial Comment on Beyond Total PSA: Clinical Significance of S2,3PSA% in Reducing Unnecessary Prostate Biopsies. | Int J Urol | 2026 | 41837352 | PubTator, text mining | PubMed |
| A single cell transcriptional profile of benign prostatic hyperplasia. | Sci Rep | 2026 | 41832222 | PubTator, text mining | PubMed |
| Molecular Characterization of KLK2 RNA Expression in Prostate Cancer. | Clin Cancer Res | 2026 | 41817312 | PubTator, text mining | PubMed |
| Transcriptomics in Venous Leg Ulcers (VLU): A Systematic Review. | Wound Repair Regen | 2026 | 41787822 | PubTator, text mining | PubMed |
| AMACR and ZFPL1 serum biomarkers enhance precision in predicting postoperative prostate cancer outcomes. | Front Oncol | 2026 | 41783436 | PubTator, text mining | PubMed |
| From prostate specific antigen to genomic signatures: Advances in biomarkers for prostate cancer diagnosis and prognosis. | Transl Oncol | 2026 | 41762538 | PubTator, text mining | PubMed |
| The Mystery of the Hidden Trace: Emerging Genetic Approaches to Improve Body Fluid Identification. | Genes (Basel) | 2026 | 41751530 | PubTator, text mining | PubMed |
| Intratumoral Androgens and Genetic Variants Driving Therapy Resistance in Prostate Cancer. | Research (Wash D C) | 2026 | 41743623 | PubTator, text mining | PubMed |
| The path forward for T cell engagers in patients with prostate cancer. | J Immunother Cancer | 2026 | 41734994 | PubTator, text mining | PubMed |
| Advancing CAR-T therapy in prostate cancer: overcoming the tumor microenvironment and enhancing efficacy. | Front Oncol | 2026 | 41717407 | PubTator, text mining | PubMed |
| Deciphering the regulatory landscape of enhancer RNAs in health and disease. | Signal Transduct Target Ther | 2026 | 41605892 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3817/papers